CNBX Pharmaceuticals, Inc. (CNBX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
CNBX Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -801.7% |
| November 30, 2023 | -199.7% |
| August 31, 2023 | -573.6% |
| May 31, 2023 | -49.87% |
| February 28, 2023 | |
| November 30, 2022 | |
| August 31, 2022 | |
| May 31, 2022 | |
| February 28, 2022 | |
| November 30, 2021 | |
| August 31, 2021 | |
| May 31, 2021 | |
| February 28, 2021 | |
| November 30, 2020 | |
| August 31, 2020 | -33.26K% |
| May 31, 2020 | -38.19K% |
| February 29, 2020 | -66.76K% |
| Date | Value |
|---|---|
| November 30, 2019 | -285.7K% |
| August 31, 2019 | -66.35K% |
| May 31, 2019 | -24.88K% |
| February 28, 2019 | |
| November 30, 2018 | -19.88K% |
| August 31, 2018 | -24.41K% |
| May 31, 2018 | -29.06K% |
| February 28, 2018 | -86.06K% |
| November 30, 2017 | -29.86K% |
| August 31, 2017 | -38.04K% |
| May 31, 2017 | -15.34K% |
| February 28, 2017 | -36.52K% |
| November 30, 2016 | |
| August 31, 2016 | -137.0% |
| May 31, 2016 | -53.00% |
| February 29, 2016 | -1.18K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.01K% |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 67.84% |
| Fulcrum Therapeutics, Inc. | -- |
| Definium Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -3.04K% |